Skip to main content
    F

    Fulgent Genetics Inc (FLGT)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ

    $24.21
    +0.13 (+0.56%)

    Market Cap: $688.98M

    Last updated: Nov 17, 2026 at 4:30 PM ET

    Fulgent Genetics Inc (FLGT) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Fulgent Genetics (FLGT) has a market cap of $688.98M and an enterprise value of $602.67M. Its share count is down 10.04% from a year earlier. It kept -27.85% of revenue as net income over the last 12 months.

    Total Valuation

    Enterprise value is 12.53% below the market cap, as cash exceeds debt.

    Market Cap$688.98M
    Enterprise Value$602.67M
    Latest price (Nov 17, 2026)$24.21

    Key Dates

    The next earnings report is expected on Feb 25, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateFeb 25, 2027 (expected)
    Last Earnings DateNov 5, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count fell 1.22% in the quarter ended Sep 30, 2026 and shrank 4.63% a year over 2 years.

    Shares Outstanding27.66M
    Shares Change (YoY)-10.04%
    Shares Change (QoQ)-1.22%
    Share Count Growth (2Y CAGR)-4.63%

    Valuation Ratios

    Sales and book value multiples are 2.0x and 0.7x. Its year-end P/S ranged from 1.5x to 9.2x from 2016 to 2025.

    P/S Ratio2.0x
    Forward P/S2.1x
    P/B Ratio0.7x
    P/TBV Ratio0.8x
    P/OCF Ratio47.8x

    Valuation history and multiples

    Price Statistics

    The stock is down 16.80% over 52 weeks and trades 12.34% above its 50-day average.

    Beta (1Y)1.08
    52-Week Change-16.80%
    1-Month Change+20.45%
    3-Month Change+22.64%
    6-Month Change+51.79%
    5-Year Change-75.13%
    10-Year Change+129.11%
    Total Return (1Y)-16.80%
    Total Return (3Y CAGR)-3.64%
    Total Return (5Y CAGR)-23.70%
    Return vs SPY (1Y)-28.36%
    Max Drawdown (1Y)-55.30%
    Max Drawdown (3Y)-55.30%
    Sharpe Ratio (1Y)-0.26
    Correlation with SPY (1Y)0.21
    50-Day Average$21.55
    200-Day Average$19.11
    52-Week Range$13.46 to $31.04
    RSI (14 Days)59.5
    Average Volume (20 Days)386.21K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 5.34x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio5.34x
    Quick Ratio5.34x
    Debt / Equity0.00x
    Interest Coverage-1307.38x

    Returns and Efficiency

    Return on invested capital is -12.14% over the last 12 months, against a 5-year average of -7.98%.

    Return on Equity (ROE)-9.29%
    Return on Assets (ROA)-8.53%
    Return on Invested Capital (ROIC)-12.14%
    ROE (5Y Average)6.01%
    ROA (5Y Average)5.39%
    ROIC (5Y Average)-7.98%
    Asset Turnover0.29x
    Receivables Turnover5.18x

    Scores

    FLGT has an Altman Z-Score of 5.12, in the safe zone above 2.99, and a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.

    Altman Z-Score5.12
    Altman Z ZoneSafe
    Piotroski F-Score3 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $330.27M over the last 12 months is up 4.67% from the 12 months before.

    Revenue$330.27M
    Revenue Growth (YoY)+4.67%
    Gross Profit$111.70M
    Operating Income-$129.48M
    Pretax Income-$98.98M
    Net Income-$91.98M
    Reported EPS (TTM)-$1.17

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 91.71% of the $1.08B in total assets.

    Cash and Equivalents$86.79M
    Total Debt$482.00K
    Net Cash$86.31M
    Net Cash Per Share$3.12
    Working Capital$311.86M
    Shareholder Equity$990.49M
    Book Value Per Share$35.81
    Tangible Book Value$789.83M
    Tangible Book Per Share$28.55
    Total Assets$1.08B
    Total Liabilities$94.22M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $15.83M of capital spending, operating cash flow left -$1.40M of free cash flow.

    Operating Cash Flow$14.43M
    Capital Expenditures$15.83M
    Free Cash Flow-$1.40M
    FCF Per Share-$0.05
    Depreciation and Amortization$29.84M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -39.20%, against a 5-year average of -4.99%.

    Gross Margin33.82%
    Operating Margin-39.20%
    Pretax Margin-29.97%
    Net Margin-27.85%
    FCF Margin-0.42%
    Gross Margin (5Y Average)50.41%
    Operating Margin (5Y Average)-4.99%
    Net Margin (5Y Average)-4.24%

    Growth

    Revenue fell 19.52% a year over 3 years, and EPS 57.76% a year.

    Revenue Growth (3Y CAGR)-19.52%
    Revenue Growth (5Y CAGR)-5.21%
    EPS Growth (3Y CAGR)-57.76%
    EPS Growth (5Y CAGR)-45.36%
    Book Value Per Share Growth (2Y CAGR)-2.70%
    Tangible Book Per Share Growth (2Y CAGR)-2.53%

    Revenue and profit by year

    Dividends and Yields

    FLGT does not pay a dividend. Its free cash flow yield is -0.21%.

    FCF Yield-0.21%
    Buyback Yield9.58%
    Shareholder Yield9.58%

    Peer Position

    Against 11 similar companies, FLGT has the 10th highest P/S.

    P/S Ratio2.0x vs 3.4x median
    ROIC-12.14% vs -4.11% median
    Revenue Growth (Trailing 4 Quarters, YoY)+4.67% vs +11.08% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 6.71% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+6.71%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewOvervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About FLGT

    What is FLGT's market cap?

    Fulgent Genetics has a market cap of $688.98M. Its enterprise value, which adds debt and subtracts cash, is $602.67M.

    How many shares of FLGT are outstanding?

    Fulgent Genetics has 27.66M shares outstanding. The count is down 10.04% from a year earlier.

    Does FLGT pay a dividend?

    No. Fulgent Genetics does not pay a dividend.

    How much debt does FLGT have?

    Fulgent Genetics has $482.00K of total debt and $86.79M of cash and equivalents, a net cash position of $86.31M.